Thalamic-Burst-DBS for Neuropathic Pain
NCT: NCT05204472 · RECRUITING
Brief Summary
Central post-stroke pain (CPSP) is a neuropathic pain syndrome and one of the major sequelae after ischemic or hemorrhagic cerebral stroke. Recently, a modified stimulation paradigm has been developed in the field of spinal cord stimulation (SCS) for a variety of neuropathic pain disorders. To date, this stimulation paradigm has not yet been evaluated systematically for deep brain stimulation to treat neuropathic pain disorders. The purpose of this clinical investigation is to investigate if Burst-DBS of the thalamus is more effective compared to classical continuous low-frequency stimulation DBS to reduce the subjective pain intensity in patients with chronic neuropathic pain after stroke or in patients with neuropathic facial pain.
Frequently Asked Questions
What is Thalamic-Burst-DBS for Neuropathic Pain?
Thalamic-Burst-DBS for Neuropathic Pain is a clinical trial registered under NCT05204472. Current status: RECRUITING.
What is the status of NCT05204472?
The current status of NCT05204472 (Thalamic-Burst-DBS for Neuropathic Pain) is: RECRUITING.
When did Thalamic-Burst-DBS for Neuropathic Pain start?
Thalamic-Burst-DBS for Neuropathic Pain started on 2022-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.